Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-01-27
6:01 pm
Sale
13GSyros Pharmaceuticals, Inc.
SYRS
Ally Bridge MedAlpha Master Fund L.P.1,439,379
6.9%
-2,491,141decrease
(-63.38%)
View
2022-02-11
4:19 pm
Sale
13GViridian Therapeutics, Inc.
VRDN
Ally Bridge MedAlpha Master Fund L.P.604,774
2.8%
-325,205decrease
(-34.97%)
View
2022-02-11
4:17 pm
Sale
13GCogent Biosciences, Inc.
COGT
Ally Bridge MedAlpha Master Fund L.P.1,501,591
3.8%
-121,000decrease
(-7.46%)
View
2022-02-11
4:17 pm
Purchase
13GSyros Pharmaceuticals, Inc.
SYRS
Ally Bridge MedAlpha Master Fund L.P.3,930,520
6.3%
897,395increase
(+29.59%)
View
2021-02-12
4:15 pm
Purchase
13GCogent Biosciences, Inc.
COGT
Ally Bridge MedAlpha Master Fund L.P.1,622,591
5.1%
1,622,591increase
(New Position)
View
2021-01-07
07:36 am
Purchase
13GViridian Therapeutics Inc.
MGEN
Ally Bridge MedAlpha Master Fund L.P.929,979
9.99%
929,979increase
(New Position)
View
2020-12-18
4:20 pm
Purchase
13GSyros Pharmaceuticals, Inc.
SYRS
Ally Bridge MedAlpha Master Fund L.P.3,033,125
5.4%
3,033,125increase
(New Position)
View